Tetralogy of Fallot (TOF)

Oncology·MeSH: Tetralogy of Fallot

Prevalence

30.0 / 100K

0 drugs in development·0 companies·1 clinical trial

Frequently asked questions

How many clinical trials target Tetralogy of Fallot (TOF)?

There are 1 clinical trial targeting Tetralogy of Fallot (TOF) tracked by BioSniper.

What is the prevalence of Tetralogy of Fallot (TOF)?

The estimated prevalence of Tetralogy of Fallot (TOF) is approximately 30.0 per 100,000 population.

Deep-dive into Tetralogy of Fallot (TOF)

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis
    Tetralogy of Fallot (TOF) — Drugs in Development & Clinical Trials | BioSniper